Please login to the form below
drug labels
This page shows the latest drug labels news and features for those working in and with pharma, biotech and healthcare.
Janssen develops digital tools to help automate clinical trials
The programme offers smart packaging, in the form of electronic drug labels, that aim to augment existing booklets but can also be supplemented with other patient-specific data.
Latest news
-
Pharma lobbying in the US
After a trial, Caronia was convicted under specific sections of the Federal Drug and Cosmetic Act (FDCA). ... The argument that in today's day and age with the rise of social media and sophisticated platforms that make data overwhelmingly easy to access
-
FDA insists on GnRH agonists risk warning
The FDA has issued a notification to manufacturers of a class of prostate cancer drug stating that new safety information must be added to labels. ... cancer, informing them that they must add new safety information to the Warnings and Precautions
-
US drug labels lacking
Drug labels in the US often are not explicit about the severity of side effects and the true efficacy of the product, according to NEJM report. ... Medicines labels in the US often do not carry information showing the severity of side effects or details
-
Under 25s at risk
People aged 25 years old and younger who take antidepressants are at much greater risk of suicide than older adults, research from the US Food and Drug Administration (FDA) has revealed. ... The findings support previous studies and the FDA's age-related
-
Hidden blockbuster?
medication, reading of labels, following of drug regimes, and finding out more information, impossible.
Pharma lobbying in the US
More from news
Approximately 0 fully matching, plus 13 partially matching documents found.
Latest Intelligence
-
Does safety sell medicines?
Is pharmacovigilance unnecessary policing or a strategic asset for pharma companies?
Does safety sell medicines?
More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest from PMHub
-
August 2020: diversity and inclusion in clinical trials round-up
Evidence of sex differences in PKs should be made available on drug labels and websites such as WebMD. ... Pharmaceutical companies should pay more attention to sex-appropriate dosing, beginning in the early drug development phases.
August 2020: diversity and inclusion in clinical trials round-up
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Account Director, Medical & Brand Communications, London/ SE...
-
Highly competitive salary
- Freelance Scientific Director, Medical Communications, London/ S...
-
Highly competitive salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Editorial Director - UK, , EUROPE, REMOTE.
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Management Trainer, Medical Communications, Londo...
-
Highly competitive salary
- Senior Account Director, Medical & Brand Communications, Lon...
-
Highly competitive salary
- EU “still interested” in Valneva COVID vaccine despite UK snub
- US demand for COVID-19 antibody treatments rising fast
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- AstraZeneca’s Imfinzi provides sustained survival benefit for lung cancer patients
- OPEN Health Acquires ARK
- Live Webinar: Artificial Intelligence for Improving Patient Outcomes & Operational Efficiency
- CHANGING FACES: UNDERSTANDING THE KEY CUSTOMER CONTACT POINTS WITHIN THE ICS LANDSCAPE
- FDA approves Seagen/Genmab’s antibody-drug conjugate Tivdak for women with advanced cervical cancer
- AstraZeneca chooses Ireland for $360m manufacturing site
- Building the perfect behaviour-change buffet
- FDA’s director and deputy director of its Office of Vaccines Research & Review resign
- Live Webinar: Making Actionable Health Information More Accessible Through Point-of-Care Testing
- David Hunt launches independent agency The Considered
- Lucid Group celebrates a double win at Communiqué 2021
- Live Webinar: Driving Healthcare Decisions with Natural Language Processing
- US orders 1.4 million more doses of Regeneron antibody cocktail
PMHub
Havas Life Medicom
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by...
Latest intelligence
- Robust Review: COVID19 Assessment
- See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
- All change – how untangling human behaviour can encourage better health
- Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
